{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:19:01Z","timestamp":1783181941230,"version":"3.54.6"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,4]]},"DOI":"10.7759\/cureus.112040","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:50:18Z","timestamp":1783180218000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Ferric Carboxymaltose Versus Oral Ferrous Sulfate for Iron Deficiency Anemia: A Retrospective Cohort Study of Iron Store Repletion and Safety"],"prefix":"10.7759","author":[{"given":"Yasmine","family":"El Ouafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inasse","family":"Mourabiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha","family":"El Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monsif","family":"Fadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Benrahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouama","family":"Bouanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-508325","article-title":"A systematic analysis of global anemia burden from 1990 to 2010","volume":"123","author":"Kassebaum NJ","year":"2014","unstructured":"Kassebaum NJ, Jasrasaria R, Naghavi M, et al.. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014, 123:615-24. 10.1182\/blood-2013-06-508325","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005","volume":"12","author":"McLean E","year":"2009","unstructured":"McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009, 12:444-54. 10.1017\/S1368980008002401","journal-title":"Public Health Nutr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/131.2.676S","article-title":"Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship","volume":"131","author":"Haas JD","year":"2001","unstructured":"Haas JD, Brownlie T 4th. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr. 2001, 131:676S-88S. 10.1093\/jn\/131.2.676S","journal-title":"J Nutr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Camaschella C","year":"2015","unstructured":"Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015, 372:1832-43. 10.1056\/NEJMra1401038","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/nu13114008","article-title":"Iron deficiency anemia in inflammatory bowel diseases - a narrative review","volume":"13","author":"Mahadea D","year":"2021","unstructured":"Mahadea D, Adamczewska E, Ratajczak AE, et al.. Iron deficiency anemia in inflammatory bowel diseases - a narrative review. Nutrients. 2021, 13:4008. 10.3390\/nu13114008","journal-title":"Nutrients"},{"key":"ref6","article-title":"Iron deficiency anemia: evaluation and management","volume":"87","author":"Short MW","year":"2013","unstructured":"Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013, 87:98-104.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz T","year":"2012","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012, 1823:1434-43. 10.1016\/j.bbamcr.2012.01.014","journal-title":"Biochim Biophys Acta"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss G","year":"2005","unstructured":"Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005, 352:1011-23. 10.1056\/NEJMra041809","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i35.7908","article-title":"Anemia and iron deficiency in gastrointestinal and liver conditions","volume":"22","author":"Stein J","year":"2016","unstructured":"Stein J, Connor S, Virgin G, Ong DE, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol. 2016, 22:7908-25. 10.3748\/wjg.v22.i35.7908","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien Z","year":"2015","unstructured":"Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015, 10:e0117383. 10.1371\/journal.pone.0117383","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.761599","article-title":"Tolerability of different oral iron supplements: a systematic review","volume":"29","author":"Cancelo-Hidalgo MJ","year":"2013","unstructured":"Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, Manasanch J, P\u00e9rez-Edo L. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin. 2013, 29:291-303. 10.1185\/03007995.2012.761599","journal-title":"Curr Med Res Opin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.220830","article-title":"Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women","volume":"105","author":"Stoffel NU","year":"2020","unstructured":"Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020, 105:1232-9. 10.3324\/haematol.2019.220830","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2450\/2014.0094-14","article-title":"Safety of intravenous iron formulations: facts and folklore","volume":"12","author":"Auerbach M","year":"2014","unstructured":"Auerbach M, Macdougall IC. Safety of intravenous iron formulations: facts and folklore. Blood Transfus. 2014, 12:296-300. 10.2450\/2014.0094-14","journal-title":"Blood Transfus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2011.09.010","article-title":"Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis","volume":"6","author":"Lee TW","year":"2012","unstructured":"Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012, 6:267-75. 10.1016\/j.crohns.2011.09.010","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296304","article-title":"The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review","volume":"60","author":"Qunibi WY","year":"2010","unstructured":"Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung. 2010, 60:399-412. 10.1055\/s-0031-1296304","journal-title":"Arzneimittelforschung"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker SD","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al.. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361:2436-48. 10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:e895-1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12006","article-title":"Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency","volume":"1","author":"Ponikowski P","year":"2014","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. ESC Heart Fail. 2014, 1:52-8. 10.1002\/ehf2.12006","journal-title":"ESC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S559861","article-title":"Impact of intravenous ferric carboxymaltose on quality of life in patients with iron deficiency anemia: a prospective observational study","volume":"18","author":"Bozku\u015f R","year":"2025","unstructured":"Bozku\u015f R, Gemcio\u011flu E, Sar\u0131\u015fen \u015e. Impact of intravenous ferric carboxymaltose on quality of life in patients with iron deficiency anemia: a prospective observational study. Int J Gen Med. 2025, 18:7459-69. 10.2147\/IJGM.S559861","journal-title":"Int J Gen Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1400009","article-title":"The safety of available treatment options for iron-deficiency anemia","volume":"17","author":"Mu\u00f1oz M","year":"2018","unstructured":"Mu\u00f1oz M, G\u00f3mez-Ram\u00edrez S, Bhandari S. The safety of available treatment options for iron-deficiency anemia. Expert Opin Drug Saf. 2018, 17:149-59. 10.1080\/14740338.2018.1400009","journal-title":"Expert Opin Drug Saf"},{"key":"ref21","article-title":"Intravenous iron-dextran: therapeutic and experimental possibilities (in German)","volume":"100","author":"Ganzoni AM","year":"1970","unstructured":"Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities (in German). Schweiz Med Wochenschr. 1970, 100:301-3.","journal-title":"Schweiz Med Wochenschr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"Evstatiev R","year":"2011","unstructured":"Evstatiev R, Marteau P, Iqbal T, et al.. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011, 141:846-53.e1-2. 10.1053\/j.gastro.2011.06.005","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002308","article-title":"Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Bonovas S","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M, Lytras T, Tsantes A, Peyrin-Biroulet L, Danese S. Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016, 95:e2308. 10.1097\/MD.0000000000002308","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0452","article-title":"Iron deficiency in adults: a review","volume":"333","author":"Auerbach M","year":"2025","unstructured":"Auerbach M, DeLoughery TG, Tirnauer JS. Iron deficiency in adults: a review. JAMA. 2025, 333:1813-23. 10.1001\/jama.2025.0452","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.103366","article-title":"Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review","volume":"102","author":"Peyrin-Biroulet L","year":"2015","unstructured":"Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015, 102:1585-94. 10.3945\/ajcn.114.103366","journal-title":"Am J Clin Nutr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040097","article-title":"Sucrosomial(\u00ae) iron: a new generation iron for improving oral supplementation","volume":"11","author":"G\u00f3mez-Ram\u00edrez S","year":"2018","unstructured":"G\u00f3mez-Ram\u00edrez S, Brilli E, Tarantino G, Mu\u00f1oz M. Sucrosomial(\u00ae) iron: a new generation iron for improving oral supplementation. Pharmaceuticals (Basel). 2018, 11:97. 10.3390\/ph11040097","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000314","article-title":"Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program","volume":"21","author":"Gasche C","year":"2015","unstructured":"Gasche C, Ahmad T, Tulassay Z, et al.. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015, 21:579-88. 10.1097\/MIB.0000000000000314","journal-title":"Inflamm Bowel Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang C","year":"2015","unstructured":"Wang C, Graham DJ, Kane RC, et al.. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA. 2015, 314:2062-8. 10.1001\/jama.2015.15572","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","author":"Avni T","year":"2015","unstructured":"Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015, 90:12-23. 10.1016\/j.mayocp.2014.10.007","journal-title":"Mayo Clin Proc"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000451069","article-title":"Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron","volume":"45","author":"Macdougall IC","year":"2017","unstructured":"Macdougall IC, Vernon K. Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron. Am J Nephrol. 2017, 45:60-2. 10.1159\/000451069","journal-title":"Am J Nephrol"},{"key":"ref31","article-title":"Clinical Epidemiology: Principles, Methods, and Applications for Clinical Research, 2nd ed","author":"Grobbee DE","year":"2015","unstructured":"Grobbee DE, Hoes AW. Clinical Epidemiology: Principles, Methods, and Applications for Clinical Research, 2nd ed. Jones &amp; Bartlett Learning, Burlington, MA; 2015."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato J","year":"2000","unstructured":"Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000, 342:1887-92. 10.1056\/NEJM200006223422507","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/frhs.2025.1690519","article-title":"Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review","volume":"5","author":"Xing Z","year":"2025","unstructured":"Xing Z, Mu S, Xue Q, Sun F, Hou G, Zhao Q. Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review. Front Health Serv. 2025, 5:1690519. 10.3389\/frhs.2025.1690519","journal-title":"Front Health Serv"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14043","article-title":"Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease","volume":"45","author":"Aksan A","year":"2017","unstructured":"Aksan A, I\u015f\u0131k H, Radeke HH, Dignass A, Stein J. Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2017, 45:1303-18. 10.1111\/apt.14043","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/505633-intravenous-ferric-carboxymaltose-versus-oral-ferrous-sulfate-for-iron-deficiency-anemia-a-retrospective-cohort-study-of-iron-store-repletion-and-safety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:50:20Z","timestamp":1783180220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/505633-intravenous-ferric-carboxymaltose-versus-oral-ferrous-sulfate-for-iron-deficiency-anemia-a-retrospective-cohort-study-of-iron-store-repletion-and-safety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.112040","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,4]]}}}